Ostarine, also called MK-2866 or enobosarm, has been investigated in animal models of osteoporosis. Those experiments explore bone density, structure and healing. They do not establish that an Ostarine product treats osteoporosis or prevents fractures in people.
What did the bone-density study find?
A study published online in 2018 examined Ostarine in female rats with experimentally induced bone loss. Some bone-density and structural measures improved, with different effects in the thigh bone and spine. However, the researchers found no significant improvement in the mechanical properties they tested. Uterine weight also increased. Read the original study.
This distinction matters: a change in a laboratory measure is not evidence that people will suffer fewer fractures. The authors called for further work on longer-term effects and adverse effects.
What does later research add?
| Research | Main finding and limitation |
|---|---|
| Female-rat bone-healing study, online 2019 | Reported changes in early healing after a controlled bone injury. It did not test recovery from injuries in people. Study |
| Male-rat osteoporosis study, 2023 | Effects depended on when treatment began. Preventive treatment affected more bone measures, but mechanical properties did not improve and prostate weight increased. Study |
| Female-rat combination study, 2025 | Examined Ostarine with raloxifene. Some bone outcomes improved, while organ and blood-chemistry findings raised safety concerns. Combination results cannot be attributed to Ostarine alone. Study |
These are different experiments with different endpoints. Their results should not be combined into a claim that Ostarine builds stronger bones or safely speeds recovery in people.
Does this establish Ostarine as an osteoporosis treatment?
No. The studies summarised here do not establish a safe, effective osteoporosis treatment for people. Findings about muscle mass in other Ostarine research also do not, by themselves, demonstrate fracture prevention.
For information about diagnosis and treatment choices, see the NHS osteoporosis treatment guide and speak with your healthcare team. Research products are not substitutes for prescribed care.
For the compound's wider research background, read our Ostarine MK-2866 guide.
Related guides